Mental Health DailyResearch. Evidence. Perspective.Published research.
In recent years, biotech and pharmaceutical companies have been developing new classes of antidepressants. These new classes attempt to improve on older classes of medication in regards to e…
Read articleIndividuals diagnosed with major depression often are found to have reduced volume within their hippocampus. The hippocampus is a small region of the brain that is responsible for regulating…
Read articleThe quest to come up with a superior antidepressant is in full effect among biotech and pharmaceutical companies. Although there are some companies that are still tweaking various formulatio…
Read articleScientists and mental health researchers have long been collecting evidence to discover what causes depression. Their goal is to find a specific neurotransmitter or system that could be targ…
Read articleNRX-1074 is a new antidepressant under development by the biotech company Naurex. It is this same company that has already been granted “fast track” status by the FDA for their intravenous a…
Read articleA new antidepressant chemically named “GLYX-13” was developed by the biotech company Naurex for individuals with treatment-resistant depression. It is currently in clinical trials as an anti…
Read articleIn a recent appointment with my therapist, he discussed how he had transformed from a mean, nasty person into a helpful, productive one. Although he was helpful in coming up with ideas for h…
Read article